Bruker Corporation $BRKR Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. cut its position in Bruker Corporation (NASDAQ:BRKR) by 86.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,943 shares of the medical research company’s stock after selling 18,730 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Bruker were worth $96,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Linden Thomas Advisory Services LLC grew its holdings in Bruker by 2.1% in the 3rd quarter. Linden Thomas Advisory Services LLC now owns 19,669 shares of the medical research company’s stock worth $639,000 after buying an additional 396 shares in the last quarter. M&T Bank Corp boosted its stake in Bruker by 2.7% during the 2nd quarter. M&T Bank Corp now owns 15,580 shares of the medical research company’s stock valued at $642,000 after purchasing an additional 411 shares in the last quarter. Arizona State Retirement System grew its holdings in Bruker by 1.4% during the third quarter. Arizona State Retirement System now owns 31,369 shares of the medical research company’s stock worth $1,019,000 after acquiring an additional 435 shares during the period. Nisa Investment Advisors LLC raised its position in Bruker by 377.5% in the second quarter. Nisa Investment Advisors LLC now owns 616 shares of the medical research company’s stock worth $25,000 after acquiring an additional 487 shares in the last quarter. Finally, Meixler Investment Management Ltd. lifted its holdings in Bruker by 4.3% in the 3rd quarter. Meixler Investment Management Ltd. now owns 12,983 shares of the medical research company’s stock valued at $422,000 after acquiring an additional 530 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Insider Buying and Selling

In other news, VP Mark Munch sold 2,000 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $49.20, for a total value of $98,400.00. Following the transaction, the vice president owned 128,443 shares of the company’s stock, valued at $6,319,395.60. This represents a 1.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 27.30% of the company’s stock.

Analysts Set New Price Targets

BRKR has been the subject of several research reports. Citigroup reduced their price objective on Bruker from $53.00 to $40.00 and set a “neutral” rating for the company in a research note on Friday, February 13th. Wells Fargo & Company upped their price objective on shares of Bruker from $48.00 to $55.00 and gave the company an “overweight” rating in a research note on Monday, December 15th. Jefferies Financial Group set a $50.00 price objective on Bruker in a research report on Thursday, February 12th. Wolfe Research upgraded shares of Bruker from a “peer perform” rating to an “outperform” rating and set a $60.00 target price for the company in a research note on Wednesday, December 10th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Bruker in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $50.38.

Bruker Price Performance

Bruker stock opened at $38.50 on Friday. Bruker Corporation has a one year low of $28.53 and a one year high of $56.22. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.73 and a quick ratio of 0.87. The business has a 50 day simple moving average of $44.90 and a 200 day simple moving average of $40.94. The company has a market capitalization of $5.86 billion, a PE ratio of -256.67, a price-to-earnings-growth ratio of 2.30 and a beta of 1.19.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Thursday, February 12th. The medical research company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.06). Bruker had a positive return on equity of 13.56% and a negative net margin of 0.25%.The firm had revenue of $977.20 million for the quarter, compared to the consensus estimate of $964.61 million. During the same period in the prior year, the company posted $0.76 earnings per share. Bruker’s quarterly revenue was down .2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, sell-side analysts forecast that Bruker Corporation will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 7th. Stockholders of record on Monday, March 23rd will be given a dividend of $0.05 per share. The ex-dividend date is Monday, March 23rd. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. Bruker’s payout ratio is currently -133.33%.

Bruker Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.